Goldman Sachs analyst Veronika Dubajova last night upgraded Fresenius SE to Buy from Neutral while lowering her price target for the shares to EUR 52 from EUR 61. The stock's 33% decline in three months has brought a "compelling entry point into a largely defensive business," Dubajova tells investors in a research note. The analyst believes Fresenius is "exposed to a number of attractive verticals with mid-to-high-single digit revenue and earnings growth potential." She looks to the company's fiscal 2018 results on February 20 as the next catalyst for the shares.